Core Viewpoint - The implementation of the new VAT law in China starting January 1, 2026, has raised concerns regarding tax obligations for the medical beauty industry, particularly the removal of VAT exemptions for profit-driven medical beauty institutions [1][4]. Group 1: Tax Policy Changes - The new VAT law specifies that "medical services provided by medical institutions" are exempt from VAT, but this exemption does not apply to profit-driven medical beauty institutions [1][4]. - The removal of VAT exemptions is aimed at ensuring that profit-driven medical beauty institutions comply with tax regulations, rather than imposing a new tax burden on consumers [1][4]. Group 2: Industry Impact and Compliance Issues - The medical beauty industry has experienced rapid growth, with the market size exceeding 300 billion yuan and approximately 20,000 legal medical beauty institutions projected for 2024 [4]. - Despite previous VAT exemptions, compliance issues have been prevalent, with cases of tax evasion reported, indicating a need for clearer regulations and enforcement [3][4]. Group 3: Market Dynamics and Future Trends - The new VAT regulations are expected to accelerate the consolidation of the medical beauty market, pushing smaller institutions with lower profit margins to exit, while larger chains may gain market share due to their compliance capabilities [5][6]. - The adjustment in tax burdens may lead to price changes in medical beauty services, with lower-cost services likely to reflect the tax increase in their pricing, while high-end services may absorb the costs to maintain customer loyalty [5][6]. Group 4: Recommendations for Compliance - Medical beauty institutions are advised to adopt best practices for compliance, including using corporate accounts for all income, accurately categorizing services for tax purposes, and ensuring consistency in contracts and invoicing [6].

Core Viewpoint - The implementation of the new VAT law in China starting January 1, 2026, will require profit-oriented medical beauty institutions to pay VAT, which has sparked widespread discussion about tax implications in the medical beauty industry [1][5]. Group 1: Tax Policy Changes - The new VAT law specifies that "medical services provided by medical institutions" are exempt from VAT, but this exemption does not apply to profit-oriented medical beauty institutions [1][5]. - The adjustment in tax policy aims to promote fair competition and standardized development within the medical beauty industry, which has seen rapid growth and an increase in the number of institutions [5][6]. Group 2: Industry Growth and Compliance Issues - The medical beauty industry in China has surpassed a market size of 300 billion yuan, with approximately 20,000 legal medical beauty institutions expected by 2024 [5]. - Despite previous tax exemptions, many medical beauty institutions have been found to engage in tax evasion practices, such as underreporting income and misclassifying taxable services [3][4]. Group 3: Impact of New Regulations - The removal of VAT exemptions may lead to price adjustments in medical beauty services, with lower-cost services likely passing on the tax burden to consumers, while high-end services may absorb the costs to maintain customer loyalty [6][7]. - The new regulations are expected to accelerate industry consolidation, with smaller institutions potentially exiting the market due to increased compliance costs, while larger chains may gain market share [6][7]. Group 4: Compliance Transformation Strategies - Medical beauty institutions are advised to adopt several compliance strategies, including using corporate accounts for all income, accurately classifying services for tax reporting, and ensuring financial transparency [7]. - Strengthening financial controls and training staff on tax policies will be crucial for institutions to navigate the new regulatory landscape effectively [7].

Core Viewpoint - The termination of South Korea's tax refund policy for medical beauty services, effective December 31, 2023, is expected to significantly impact the medical tourism industry, which has thrived on this incentive for nearly a decade [1][2]. Group 1: Policy Changes - The tax refund policy, which allowed foreign patients to claim a 10% VAT refund on medical beauty services exceeding 30,000 KRW (approximately 143.7 CNY), has been officially removed from the revised Tax Special Cases Limitation Act [1][2]. - This policy was instrumental in attracting a large number of overseas medical beauty tourists, contributing to the growth of South Korea's medical tourism sector [1][2]. Group 2: Economic Impact - The total medical expenditure by foreign patients in South Korea is projected to rise from approximately 400 billion KRW (about 1.912 billion CNY) in 2019 to 12.4 trillion KRW (around 59.272 billion CNY) by 2024 [2]. - The cancellation of the tax refund is expected to increase the cost of medical services for foreign patients, potentially leading to a significant decrease in medical beauty tourists [4]. Group 3: Industry Response - Industry professionals have expressed strong opposition to the policy change, warning that it could diminish South Korea's status as a leading destination for medical tourism, especially as other countries enhance their competitive advantages [6]. - Analysts suggest that while the immediate impact of the tax refund cancellation may be limited, the long-term success of South Korea's medical beauty industry will depend on maintaining high standards of quality, reputation, and safety [7].

Group 1 - The core viewpoint of the article highlights the rapid growth of Mexico's medical tourism industry, particularly in cosmetic surgery, attracting a significant number of international patients from North America and Europe [1][2] - According to ISAPS, Mexico ranks second globally in the proportion of foreign cosmetic surgery patients, accounting for 35.1%, following Colombia [1] - In 2024, Mexico is expected to receive 1.4 million international patients, generating revenue of up to $8 billion, with cosmetic surgery services making up 40% of this revenue [1] Group 2 - The surge in medical tourism is largely driven by social media, with influencers sharing their experiences, significantly increasing visibility and interest in cosmetic procedures [1] - Mexico's medical aesthetic market is attractive due to its cost-effectiveness, with services offered at one-third the price of similar procedures in the United States [2] - Despite the market's growth, concerns about risks and irregularities have emerged, including the closure of 97 illegal clinics by health authorities in the past three years, with 48 located in Mexico City [2]

Core Viewpoint - The beauty and cosmetic surgery market is expanding due to the increasing demand for "self-care consumption," despite ongoing issues with pricing irregularities in the industry [1][2]. Group 1: Regulatory Developments - The National Healthcare Security Administration has issued a "Guideline for the Pricing of Cosmetic Surgery Medical Services (Trial)," establishing 101 cosmetic surgery projects to standardize pricing and regulate medical institutions' pricing behavior [1][3]. - The guideline does not change the market-adjusted pricing management method but aims to unify pricing items and promote a more transparent and orderly market environment [1]. Group 2: Project Classification and Pricing - The guideline provides detailed classifications for cosmetic surgery projects, such as subdividing lip enhancement into various categories like "red lip" and "lip pearl" [2]. - For well-known projects like hair transplantation, the guideline introduces a "taxi-style pricing scheme," where pricing is based on the number of units beyond a basic charge [2]. Group 3: Industry Impact and Future Directions - The measures are expected to help consumers understand the essence of the technology through project names and address the confusion of "same name, different price" and "same price, different quality" among medical institutions [2]. - The guideline allows qualified medical institutions to set additional and expanded items conditionally, which can facilitate the introduction of new technologies and materials into services [2].

Core Points - The National Healthcare Security Administration (NHSA) has released a guideline for the pricing of cosmetic surgery services, aiming to standardize and regulate the pricing of cosmetic procedures [1][2] - The guideline includes 101 cosmetic surgery projects, such as injection fees, rhinoplasty fees, and fat transfer fees, with a focus on clear and understandable naming conventions for services [1][3] - The guideline introduces a policy for additional charges for revision surgeries, recognizing the increased technical demands and time required for such procedures [2] Group 1 - The guideline standardizes the naming of cosmetic surgery services, making it easier for patients to understand the procedures and associated costs [1][3] - It includes new pricing projects for "reduction tension suturing" and "incision cosmetic modification," encouraging medical institutions to minimize scar formation through advanced techniques [3] - Most of the cosmetic procedures outlined in the guideline are not covered by health insurance and are considered out-of-pocket expenses, allowing medical institutions to set their own pricing [3] Group 2 - The guideline addresses the issue of varying quality among medical institutions in the cosmetic surgery field, which can lead to unsatisfactory results for patients [2] - It emphasizes the importance of transparency and fairness in pricing, encouraging institutions to publicly disclose their pricing structures [3] - The NHSA aims to guide provincial healthcare authorities to adopt the guidelines and assist qualified medical institutions in setting reasonable prices based on quality and service [3]